De Duve Institute

Publications


Complete publication list (Pubmed search) :

>> Link  (Pierre van der Bruggen)

>> Link  (Danièle Godelaine)

>> Link  (Didier Colau)



Representative publications :

A galectin-3 ligand corrects thse impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
Demotte N, Wieërs G, Van Der Smissen P, Moser M, Schmidt CW, Thielemans K, Squifflet J-L, Weynand B, Carrasco J, Lurquin C, Courtoy PJ, van der Bruggen P.
Cancer Res. 2010, 70: 7476-88

Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.
Demotte N, Stroobant V, Courtoy PJ, Van Der Smissen P, Colau D, Luescher IF, Hivroz C, Nicaise J, Squifflet JL, Mourad M, Godelaine D, Boon T, van der Bruggen P.
Immunity. 2008, 28:414-24

Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells.
Carrasco J, Van Pel A, Neyns B, Lethé B, Brasseur F, Renkvist N, van der Bruggen P, van Baren N, Paulus R, Thielemans K, Boon T, Godelaine D.
J Immunol. 2008, 180:3585-93

CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation.
Carrasco J, Godelaine D, Van Pel A, Boon T, van der Bruggen P.
Blood. 2006, 108:2897-905

Human T cell responses against melanoma.
Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P.
Annu Rev Immunol. 2006;24:175-208. Review.

A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells.
Zhang Y, Renkvist N, Sun Z, Schuler-Thurner B, Glaichenhaus N, Schuler G, Boon T, van der Bruggen P, Colau D.
Eur J Immunol. 2005, 35:1066-75

Tumor-specific shared antigenic peptides recognized by human T cells.
Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T.
Immunol Rev. 2002, 188:51-64

A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling.
Demotte N, Colau D, Ottaviani S, Godelaine D, Van Pel A, Boon T, van der Bruggen P.
Eur J Immunol. 2002, 32:1688-97

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T.
Science. 1991, 254:1643-7